NINTEDANIB
Generic: NINTEDANIB
Sandoz IncManufacturer
ORALRoute
NINTEDANIB ESYLATEActive Substance
2026-04-02Original Approval
NINTEDANIB is FDA application ANDA216915, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
717 reports
2
DEATH
439 reports
3
NAUSEA
307 reports
4
IDIOPATHIC PULMONARY FIBROSIS
254 reports
5
MALIGNANT NEOPLASM PROGRESSION
237 reports
6
DISEASE PROGRESSION
209 reports
7
VOMITING
202 reports
8
DYSPNOEA
199 reports
9
INTERSTITIAL LUNG DISEASE
185 reports
10
OFF LABEL USE
184 reports